The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Triiodothyronine and Thyroxine in Hyperthyroidism COMPARISON OF THE ACUTE CHANGES DURING THERAPY WITH ANTITHYROID AGENTS
Open accessAbstract
In 66 untreated patients with hyperthyroidism, serum triiodothyronine (T(3)) and thyroxine (T(4)) concentrations were measured by immunoassay. The mean T(3) level was 478+/-28 ng/100 ml (all values mean+/-SEM) and the T(4) was 20.6+/-0.6 mug/100 ml. The serum T(4)/T(3) ratio by weight was 48+/-2 as opposed to a value of 71+/-3 in euthyroid adults. There was a significant inverse correlation of the T(4)/T(3) ratios with serum T(3) (r=0.77; P<0.01) but not with serum T(4)(r=0.21). These results suggested that relative overproduction of T(3) is consistently present in patients with hyperthyroidism. To examine the acute effects of various antithyroid agents on serum T(3) and T(4) concentrations, iodide, propylthiouracil (PTU), and methylmercaptoimidazole (MMI) were given alone to mine patients, and serial T(3) and T(4) measurements were made. There was an acute decrease in serum T(3) over the first 5 days in the three iodide and three PTU-treated patients which was greater than that seen in the MMI group. This suggested that PTU and MMI had different effects on T(3) production. To compare the effects of PTU and MMI under conditions in which thyroidal hormone release was minimized, these drugs were given in combination with iodide. The mean daily dosage of PTU was 827 (n=11) and of MMI was 88 (n=8). In the PTU+iodide group, the initial serum T(3) concentration was 586+/-61 ng/100 ml and decreased significantly to 326+/-41 on day 1 and to 248+/-21 on days 2 and 3, respectively, and did not change further on days 4 and 5. In the MMI + iodide group, basal serum T(3) was 645+/-90 ng/100 ml and decreased to 568+/-81, 452+/-73, and 344+/-51 on days 1, 2, and 3, respectively, and did not change thereafter. While the initial T(3) concentrations in serum were not different in the PTU and MMI groups, the T(3) concentrations in the PTU patients were significantly lower on days 1 and 2 and during the apparent plateau period on days 3-5. Serum T(4) concentrations decreased gradually in both groups, from 23.9+/-2.0 mug/100 ml, initially, to 17.5+/-1.6 on day 5 in the PTU group and from 22.0+/-2.6 to 14.6+/-2.0 in the MMI-treated patients. The T(4) values were not significantly different at any time. These changes resulted in increases in the serum T(4)/T(3) ratios in both groups, but these ratios were substantially higher in the patients treated with PTU + iodide. The initial serum T(4)/T(3) ratio was 43+/-3 and increased to 74+/-7 and 88+/-7 on days 1 and 2 in the PTU group, reaching a plateau value of 91+/-7 during days 3-5. Comparable values for MMI-treated patients were 35+/-2, 42+/-3, 52+/-6, and 54+/-3 during the plateau period. Previous investigations have shown that PTU inhibits T(4) deiodination in hyperthyroid patients and decreases T(3) production from T(4) in animals. The greater acute decrease in serum T(3) and the higher serum T(4)/T(3) ratios in the PTU-treated patients seems best explained by an inhibition of peripheral T(3) production by this agent. This conclusion is further supported by a direct relationship between the T(4)/T(3) ratio on days 3-5 and the dose of PTU administered. These results further suggest that both thyroidal and extrathyroidal pathways contribute substantially to the apparent overproduction of T(3) in hyperthyroidism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A number of therapeutic measures are specifically intended to decrease T 4 -to-T 3 conversion, such as the preferential use of PTU over MMI (229,230), glucocorticoid therapy (231), and the use of b-adrenergic blocking agents such as propranolol, with selective ability to inhibit type 1 deiodinase (232).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [229]
In the citing paper
“For example, an early article comparing acute changes in thyroid hormone level after initiation of PTU or MMI found that T 3 levels dropped by approximately 45% in the first 24 hours of PTU therapy compared to an approximately 10%-15% decrease after starting MMI (229).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [229]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Propylthiouracil inhibits the conversion of l-thyroxine to l-triiodothyronine
Oppenheimer, J. H., Schwartz, H. L., & Surks, M. I. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107063 · Cited by 258
Simultaneous Measurement of Thyroxine and Triiodothyronine Peripheral Turnover Kinetics in Man
Nicoloff, J. T., LOW, J. C., Dussault, J. H., & Fisher, D. A. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106835 · Cited by 217
Direct immunoassay of triiodothyronine in human serum
Larsen, P. R. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107000 · Cited by 205
Self-citationQuantitation of extrathyroidal conversion of l-thyroxine to 3,5,3′-triiodo-l-thyronine in the rat
Schwartz, H. L., Surks, M. I., & Oppenheimer, J. H. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106584 · Cited by 173
Wartofsky, L., Ransii, B. J., & Ingbar, S. H. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106225 · Cited by 141
Immunoassay of Thyroxine in Unextracted Human Serum
Larsen, P. R., DOCKALOVA, J., Sipula, D., & WU, F. M. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-2-177 · Cited by 139
Self-citationTriiodothyronine: Review of recent studies of its physiology and pathophysiology in man
Larsen, P. R. (1972) · Metabolism · doi:10.1016/0026-0495(72)90038-8 · Cited by 137
Self-citationStanley, M. M. (1949) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-9-10-941 · Cited by 112
The effect of stable iodide on thyroid secretion in man.
DeGroot, L. J., & Greer, M. A. (1956) · PubMed · Cited by 63
THE EFFECT OF IODIDE ON THE RELEASE OF THYROID HORMONE IN HYPERTHYROIDISM*
GOLDSMITH, R. E., & Eisele, M. L. (1956) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-16-1-130 · Cited by 49
Research works printed but not linked: 1
- Ingbar, S. H., and K. A. Woeber. 1968. The thyroid gland. In Textbook of Endocrinology. R. H. Williams, editor. W. B. Saunders Company, Philadelphia. 4th edition. 214.
Cited by
Sorted by citations
Items 101–157 of 157
Huang, S. A., & Castroneves, L. A. (2010) · Endocrine updates · doi:10.1007/978-1-4419-1485-9_1 · Cited by 5
Creo, A. L., Cannon, B. C., & Pittock, S. T. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0072 · Cited by 5
Molnár, I., Szentmiklósi, J., & Somogyiné-Vári, É. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-113831 · Cited by 4
Duntas, L. H., & Žarković, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae543 · Cited by 4
Arecoline inhibits pineal–testis function in experimentally induced hypothyroid rats
Saha, I., Chakraborty, S. B., Chatterjee, A., Pradhan, D., Chatterji, U., & Maiti, B. R. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1486428 · Cited by 4
Ligand Regulation and Nuclear Receptor Action
Hewison, M. (2010) · Springer eBooks · doi:10.1007/978-90-481-3303-1_16 · Cited by 4
Bianco, A. C., & Kim, B. W. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4745-2.00005-5 · Cited by 4
Larsen, P. R. (1976) · Disease-a-Month · doi:10.1016/s0011-5029(76)80004-1 · Cited by 4
Self-citationMontgomery, D. A. D. (1979) · PubMed Central · Cited by 4
Endocrine Function in the Critically III
TEICH, S. A., Sharpe, S. M., & Chernow, B. (1985) · Clinics in Anaesthesiology · doi:10.1016/s0261-9881(21)00102-6 · Cited by 4
Bürgi, H., Labhart, A., Hedinger, C. E., Kistler, G., & Prader, A. (1978) · Springer eBooks · doi:10.1007/978-3-662-08098-6_6 · Cited by 4
A Comparison of ATA and Updated ACOG Guidelines for Thyroid Disease in Pregnancy
Pearce, E. N. (2020) · Clinical Thyroidology · doi:10.1089/ct.2020;32.317-320 · Cited by 3
Deiodinase Enzymes and Their Activities in Graves’ Hyperthyroidism
Molnár, I. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97007 · Cited by 5
Kamikubo, K., KOJIMA, N., Yamakita, N., & Miura, K. (1986) · Japanese Journal of Medicine · doi:10.2169/internalmedicine1962.25.186 · Cited by 3
Diltiazem-Induced Reversible Cardiogenic Shock in Thyroid Storm
Sakaan, R. A., Poole, M. A., & Long, B. (2021) · Cureus · doi:10.7759/cureus.19261 · Cited by 3
Clinical Aspects and Diagnosis of Thyroid Hormone Transport Protein Anomalies
Langsteger, W. (1997) · Current topics in pathology · doi:10.1007/978-3-642-60531-4_10 · Cited by 3
Maia, A. L. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0619 · Cited by 3
Case Report Hyperthyroxinemia and Hypotriiodothyroninemia with Clinical Euthyroidism
Amico, J. A., & DeRubertis, F. R. (1981) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198105000-00006 · Cited by 3
Shigemasa, C., Kyôju, A. B. E., Taniguchi, S., Mitani, Y., Ueta, Y., URABE, K., ADACHI, T., Tanaka, T., Yoshida, A., & Mashiba, H. (1987) · Endocrinologia Japonica · doi:10.1507/endocrj1954.34.821 · Cited by 3
Bürgi, H. (1986) · Springer eBooks · doi:10.1007/978-3-642-70509-0_6 · Cited by 3
Molnár, I., Szentmiklósi, J., Gesztelyi, R., & Somogyiné-Vári, É. (2019) · Clinical and Experimental Medicine · doi:10.1007/s10238-018-00542-7 · Cited by 2
Antithyroid Drug Therapy in Patients with Graves’ Disease
Laurberg, P., & Cooper, D. S. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2534-6_6 · Cited by 2
Hormonal therapy during pregnancy
Hays, P. M., & Cruikshank, D. P. (1985) · Elsevier eBooks · doi:10.1016/b978-0-407-02301-7.50012-4 · Cited by 2
The treatment of hyperthyroidism
Hartzband, P., & Solomon, D. H. (1981) · Disease-a-Month · doi:10.1016/s0011-5029(81)80003-x · Cited by 2
Rational Therapy for Thyroid Storm*
Carter, J. N., Eastman, C. J., Kilham, H. A., & Lazarus, L. (1975) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1975.tb03057.x · Cited by 2
Kon, Y. C., Lim, B. S. P., Lee, Y., Aw, S. E., & Wong, Y. (2020) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.035.02.13 · Cited by 1
Tormenta tiroidea: abordaje diagnóstico y terapéutico
Correa-Guerrero, J., Santander, H. C., Yepes, J., Simanca, J. D. B., Arrieta, L. R., Castellanos-Pinedo, A., Garizabalo, E. R., & Castell, C. R. D. (2024) · Acta Colombiana de Cuidado Intensivo · doi:10.1016/j.acci.2024.10.010 · Cited by 1
Thyroid Disorders During Pregnancy, Postpartum, and Lactation
Quandt, Z., Salmeen, K. E., & Block-Kurbisch, I. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00019-2 · Cited by 2
Age-dependent response to T4 overtreatment and recovery on systemic and organ level
Kerp, H., Renko, K., Hönes, G. S., Brix, K., Köhrle, J., Moeller, L. C., & Führer, D. (2021) · Journal of Molecular Endocrinology · doi:10.1530/jme-21-0109 · Cited by 1
Hollander, J. M., & Davies, T. F. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4745-2.00012-2 · Cited by 1
Severe Thyrotoxicosis and Thyroid Storm
Lechner, M. G., & Angell, T. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-38976-5_4 · Cited by 1
Sudden Unexpected Death in Endocrine Diseases
Wang, Z., Zhang, H., & Chong, W. (2020) · Springer eBooks · doi:10.1007/978-981-15-7002-5_20 · Cited by 1
Severe Thyrotoxicosis and Thyroid Storm
Lechner, M. G., & Angell, T. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-76097-3.00001-6 · Cited by 1
Dahlberg, P. A., Karlsson, F. A., & WIDE, L. E. (1980) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1980.tb09741.x · Cited by 1
SALOMON-MONTAVON, N. A., & Burger, A. (1984) · Journal of Endocrinological Investigation · doi:10.1007/bf03348457 · Cited by 1
Dong, B. J. (1992) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-13175-4_71 · Cited by 1
Isolated High Serum Triiodothyronine Levels
Soler, N. G. (1979) · Archives of Internal Medicine · doi:10.1001/archinte.139.1.36 · Cited by 1
Scholz, P. M. (2009) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-5624
Metabolism in Response to Propylthiouracil, Dexamethasone, and Thyroxine Administration in Man
LoPresti, J. S., Eigen, A., Kaptein, E. M., Anderson, K. P., Spencer, C. A., & Nicoloff, J. T. (1989)
Regional adjustment of thyroid hormone reference intervals
Ganslmeier, M., Castrop, C., Scheidhauer, K., Rondak, I., & Luppa, P. B. (2014) · Journal of Laboratory Medicine · doi:10.1515/labmed-2014-0008
Kaplan, M. M., & Meier, D. A. (2000) · Endocrine updates · doi:10.1007/978-1-4615-4407-4_10
Antoniades, H. N. (1977) · Elsevier eBooks · doi:10.1016/b978-0-12-568403-3.50013-1
Dunikoski, L. K. (1982) · Elsevier eBooks · doi:10.1016/b978-0-12-657102-8.50011-4
Comparison of ATA and Updated ACOG Guidelines for Thyroid Disease in Pregnancy. Russian translation
Pearce, E. N. (2021) · Clinical and experimental thyroidology · doi:10.14341/ket12556
Endocrine Hypertensive Emergencies
Egan, C. E., Greenberg, J. A., & Fahey, T. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-84737-1_42
Daggett, P. (1983) · Springer eBooks · doi:10.1007/978-1-4471-3498-5_34
Rosenberg, I. N. (1976) · Pharmacology & Therapeutics Part C Clinical Pharmacology and Therapeutics · doi:10.1016/s0362-5486(76)80028-3
Acute anxiety and tachycardia in a hospitalized 59-year-old woman
Applewhite, A. I., Stancampiano, F. F., Harris, D. M., Bernet, V. J., Cernigliaro, J. G., & Valery, J. R. (2022) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.89a.21002
Can Methimazole Replace Propylthiouracil in the Treatment of Thyroid Storm?
Endo, M. (2023) · Clinical Thyroidology · doi:10.1089/ct.2023;35.229-231
Transcriptomic landscape of hyperthyroidism in mice overexpressing thyroid-stimulating hormone
Yamauchi, I., Sugawa, T., Hakata, T., Yoshizawa, A., Kita, T., Kishimoto, Y., Kimura, S., Sakurai, A., 小杉, 大., Fujita, H., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111565
Drug effects and thyroid function
Klose, M., Feldt‐Rasmussen, U., & Rasmussen, Å. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00300-9
Brennan, M. D. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)38196-6
Therapeutic Plasma Exchange in Severe Thyrotoxicosis: Clinical Observations From a Case Series
Calderón, A., Aguilera, M. C., Rojas, A. P., Patham, B., & Shakil, J. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf649
Étude du signal véhiculé par les hormones thyroïdiennes dans la physiopathologie intestinale
Castillo, L. J. U. (2017) · theses.fr (ABES) · doi:10.70675/5eb82d1az104az4ee8zb7aczd71f878a8501
Gènes cibles des hormones thyroïdiennes, un regard nouveau par le prisme des analyses pangénomiques
Zekri, Y. (2022) · theses.fr (ABES) · doi:10.70675/f8d646ffzf184z40e1z848az174a3d652f5d
Diagnosis and Management of Thyroid Storm
Warnock, A., & Burch, H. B. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2534-6_9
Metadata
- Authors
- Abuid, J., & Larsen, P. R.
- Affiliations
- University of Pittsburgh (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1974-07-01
- Volume
- 54
- Issue
- 1
- Pages
- 201-208
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC301541
- OpenAlex
- W2081779848
- Cited by
- 156
- References
- 17
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 8 · 2020: 5 · 2019: 6 · 2018: 3 · 2017: 9 · 2016: 4 · 2015: 2 · 2014: 1 · 2012: 1
- FWCI
- 6.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- hyperthyroidism, triiodothyronine, thyroxine, T3/T4 ratio, antithyroid drugs, propylthiouracil, methimazole, iodide, thyroid hormone synthesis, thyroid hormone secretion
- MeSH terms
- Dose-Response Relationship, Drug, Humans, Hyperthyroidism, Iodine, Methimazole, Propylthiouracil, Antithyroid Agents, Thyroid Gland, Thyroxine, Triiodothyronine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
